Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

325

HTML

2461

Figures (1-2)

174

Tables (1-2)

163

Sum=3123

Mar 14, 2008 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Mar 14, 2008; 14(10): 1617-1621
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1617

Figure 1 Morphology of DCs on d 8 (× 400) in healthy control group (A), CHB control group (B), and ETV treatment group (C).

Figure 2 Secretion of IL-12 and IL-6 from different groups of patients (^aP < 0. 05 vs ETV; ^bP < 0.01 vs CHB control).

Citation: Lu GF, Tang FA, Zheng PY, Yang PC, Qi YM. Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B. World J Gastroenterol 2008; 14(10): 1617-1621
URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1617.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1617